NYSE:CHE
Chemed Corp Stock News
$564.34
-1.18 (-0.209%)
At Close: May 20, 2024
Chemed Corporation to Present at the Oppenheimer 32nd Annual Healthcare Conference
04:30pm, Wednesday, 09'th Mar 2022 Business Wire
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022, at approximately 8:40 a.m. (ET). The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be a
Chemed Corporation to Present at the Oppenheimer 32nd Annual Healthcare Conference
11:30am, Wednesday, 09'th Mar 2022
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022
Here's Why You Should Retain Chemed (CHE) Stock For Now
01:37pm, Tuesday, 08'th Mar 2022 Zacks Investment Research
Investors are optimistic about Chemed's (CHE) better-than-expected earnings and robust performance by the Roto-Rooter arm.
Here's Why You Should Retain Chemed (CHE) Stock For Now
09:47am, Tuesday, 08'th Mar 2022
Investors are optimistic about Chemed's (CHE) better-than-expected earnings and robust performance by the Roto-Rooter arm.
Chemed (CHE) Roto-Rooter Sales Robust Despite COVID-19 Woes
09:45am, Monday, 07'th Mar 2022
Chemed's (CHE) Roto-Rooter business gains from growing demand for plumbing, drain cleaning and excavation and water restoration services.
Chemed Corp – Consensus Indicates Potential 20.8% Upside
10:21am, Tuesday, 01'st Mar 2022 DirectorsTalk
Chemed Corp found using ticker (CHE) have now 4 analysts covering the stock with the consensus suggesting a rating of ''Strong_Buy''. The target price ranges between 609 and 560 with a mean TP of 581. Given that the stocks previous close was at 480.78 this now indicates there is a potential upside of 20.8%. The 50 day MA is 487.71 while the 200 day moving average is 477.72. The market capitalisation for the company is $7,363m. Visit the company website at: https://www.chemed.com [stock_market_widget type="chart" template="basic" color="green" assets=CHE" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $8,898m based on the market concensus. Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations.
Chemed Corporation (CHE) CEO Kevin McNamara on Q4 2021 Results - Earnings Call Transcript
09:32pm, Friday, 25'th Feb 2022 Seeking AlphaChemed Corporation (CHE) CEO Kevin McNamara on Q4 2021 Results - Earnings Call Transcript
04:32pm, Friday, 25'th Feb 2022
Chemed Corporation (CHE) CEO Kevin McNamara on Q4 2021 Results - Earnings Call Transcript
Chemed (CHE) Q4 Earnings Surpass Estimates, Revenues Miss
01:58pm, Friday, 25'th Feb 2022 Zacks Investment Research
Chemed (CHE) reports better-than-expected earnings for the fourth quarter, with a robust performance by the Roto-Rooter arm driving the top line.
Chemed (CHE) Q4 Earnings Surpass Estimates
11:50pm, Thursday, 24'th Feb 2022 Zacks Investment Research
Chemed (CHE) delivered earnings and revenue surprises of 3.75% and 0.61%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Chemed Non-GAAP EPS of $5.25 beats by $0.17, revenue of $541M misses by $2.18M
09:56pm, Thursday, 24'th Feb 2022 Seeking Alpha
Chemed press release (NYSE:CHE): Q4 Non-GAAP EPS of $5.25 beats by $0.17.Revenue of $541M (+1.4% Y/Y) misses by $2.18M.
Chemed Reports Fourth-Quarter 2021 Results
09:15pm, Thursday, 24'th Feb 2022 Business Wire
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2021, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 1.4% to $541 million GAAP D
Chemed (CHE) Q4 Earnings Surpass Estimates
08:00pm, Thursday, 24'th Feb 2022
Chemed (CHE) delivered earnings and revenue surprises of 3.75% and 0.61%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Chemed Q4 2021 Earnings Preview (NYSE:CHE)
10:35pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Chemed (NYSE:CHE) is scheduled to announce Q4 earnings results on Thursday, February 24th, after market close.The consensus EPS Estimate is $5.08 (-1.0% Y/Y) and the consensus…
Chemed declares $0.36 dividend
05:32pm, Friday, 18'th Feb 2022 Seeking Alpha
Chemed (NYSE:CHE) declares $0.36/share quarterly dividend, in line with previous.Forward yield 0.31%Payable March 18; for shareholders of record Feb. 28; ex-div Feb.